Presumably hospital-transmitted Clostridium difficile infections based on epidemiological linkage

Philipp Kohler; Andrea Bregenzer-Witteck; Philippe Rafeiner; Matthias Schlegel

doi:10.4414/smw.2013.13824

Original article

Vol. 143 No. 2930 (2013)

Presumably hospital-transmitted Clostridium difficile infections based on epidemiological linkage

Philipp Kohler
Andrea Bregenzer-Witteck
Philippe Rafeiner
Matthias Schlegel

DOI: https://doi.org/10.4414/smw.2013.13824
Cite this as:: Swiss Med Wkly. 2013;143:w13824
Published: 14.07.2013

References

Bartlett JG. Antibiotic-associated diarrhea. N Engl J Med. 2002;346(5):334–9.
Pépin J, Valiquette L, Alary ME, Villemure P, Pelletier A, Forget K, et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ. 2004;171(5):466–72.
Kuijper EJ, Barbut F, Brazier JS, Kleinkauf N, Eckmanns T, Lambert ML, et al. Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Eurosurveillance, Volume 13, Issue 31, 31 July 2008.
Gerding DN, Johnson S, Peterson LR, Mulligan ME, Silva J Jr. Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol. 1995;16(8):459–77.
Shaughnessy MK, Micielli RL, DePestel DD, Arndt J, Strachan CL, Welch KB, et al. Evaluation of hospital room assignment and acquisition of Clostridium difficile infection. Infect Control Hosp Epidemiol. 2011;32(3):201–6.
Chang VT, Nelson K. The role of physical proximity in nosocomial diarrhea. Clin Infect Dis. 2000;31(3):717–22. Epub 2000 Oct 4.
Shim JK, Johnson S, Samore MH, Bliss DZ, Gerding DN. Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea. Lancet. 1998;351(9103):633–6.
Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, et al.; Society for Healthcare Epidemiology of America; Infectious Diseases Society of America. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31(5):431–55.
Wilkinson K, Gravel D, Taylor G, McGeer A, Simor A, Suh K, et al.; Canadian Nosocomial Infection Surveillance Program. Infection prevention and control practices related to Clostridium difficile infection in Canadian acute and long-term care institutions. Am J Infect Control. 2011;39(3):177–82.
Walker AS, Eyre DW, Wyllie DH, Dingle KE, Harding RM, O’Connor L, et al. Characterisation of Clostridium difficile hospital ward-based transmission using extensive epidemiological data and molecular typing. PLoS Med. 2012;9(2):e1001172. Epub 2012 Feb 7.
Palmore TN, Sohn S, Malak SF, Eagan J, Sepkowitz KA. Risk factors for acquisition of Clostridium difficile–associated diarrhea among outpatients at a cancer hospital. Infect Control Hos Epidemiol. 2005;26(8):680–4.
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.
Crobach MJ, Dekkers OM, Wilcox MH, Kuijper EJ. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI). Clin Microbiol Infect. 2009;15(12):1053–66. doi: 10.1111/j.1469-0691.2009.03098.x.
McDonald LC, Coignard B, Dubberke E, Song X, Horan T, Kutty PK; Ad Hoc Clostridium difficile Surveillance Working Group. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol. 2007;28(2):140–5. Epub 2007 Jan 25.
Fenner L, Frei R, Gregory M, Dangel M, Stranden A, Widmer AF. Epidemiology of Clostridium difficile-associated disease at University Hospital Basel including molecular characterisation of the isolates 2006–2007. Eur J Clin Microbiol Infect Dis. 2008;27(12):1201–7. Epub 2008 Jun 17.
Bauer MP, Notermans DW, van Benthem BH, Brazier JS, Wilcox MH, Rupnik M, et al.; ECDIS Study Group. Clostridium difficile infection in Europe: a hospital-based survey. Lancet. 2011;377(9759):63–73.
Khanna S, Pardi DS, Aronson SL, Kammer PP, Orenstein R, St Sauver JL, et al. The epidemiology of community-acquired Clostridium difficile infection: a population-based study. Am J Gastroenterol. 2012;107(1):89–95. doi: 10.1038/ajg.2011.398. Epub 2011 Nov 22. Erratum in: Am J Gastroenterol. 2012;107(1):150.
Morrison RH, Hall NS, Said M, Rice T, Groff H, Brodine SK, et al. Risk Factors Associated With Complications and Mortality in Patients With Clostridium difficile Infection. Clin Infect Dis. 2011;53(12):1173–8. Epub 2011 Oct 5.
McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med. 1989;320(4):204–10.
Sax H, Allegranzi B, Chraïti MN, Boyce J, Larson E, Pittet D. The World Health Organization hand hygiene observation method. Am J Infect Control. 2009;37(10):827–34.

How to Cite

1.

Kohler P, Bregenzer-Witteck A, Rafeiner P, Schlegel M. Presumably hospital-transmitted Clostridium difficile infections based on epidemiological linkage. Swiss Med Wkly [Internet]. 2013 Jul. 14 [cited 2024 Apr. 18];143(2930):w13824. Available from: https://smw.ch/index.php/smw/article/view/1713

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Most read articles by the same author(s)

Cristina Bellini, Marcus Eder, Laurence Senn, Rami Sommerstein, Danielle Vuichard-Gysin, Yvonne Schmiedel, Matthias Schlegel, Stephan Harbarth, Nicolas Troillet, Providing care to patients in contact isolation: is the systematic use of gloves still indicated? , Swiss Medical Weekly: Vol. 152 No. 0506 (2022)
Sarah L. Thiel, Myriam C. Weber, Lorenz Risch, Nadia Wohlwend, Thomas Lung, Dorothea Hillmann, Michael Ritzler, Martin Risch, Philipp Kohler, Pietro Vernazza, Christian R Kahlert, Felix Fleisch, Alexia Cusini, Tomas V. Karajan, Sandra Copeland, Matthias Paprotny, Flattening the curve in 52 days: characterisation of the COVID-19 pandemic in the Principality of Liechtenstein – an observational study , Swiss Medical Weekly: Vol. 150 No. 4142 (2020)
Aliki Metsini, Andreas Widmer, Walter Zingg, Céline Gardiol, Danielle Vuichard-Gysin, Marcus Eder, Judith Maag, Matthias Schlegel, Jonas Marschall, Stephan Harbarth, Rami Sommerstein, Evaluation of existing and desired measures to monitor, prevent and control healthcare-associated infections in Swiss hospitals , Swiss Medical Weekly: Vol. 151 No. 2728 (2021)
Giulia Scanferla, Delphine Héquet, Nicole Graf, Thomas Münzer, Simone Kessler, Philipp Kohler, Andres Nussbaumer, Christiane Petignat, Matthias Schlegel, Domenica Flury, COVID-19 burden and influencing factors in Swiss long-term-care facilities: a cross-sectional analysis of a multicentre observational cohort , Swiss Medical Weekly: Vol. 153 No. 3 (2023)

[1] Bartlett JG. Antibiotic-associated diarrhea. N Engl J Med. 2002;346(5):334–9.

[2] Pépin J, Valiquette L, Alary ME, Villemure P, Pelletier A, Forget K, et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ. 2004;171(5):466–72.

[3] Kuijper EJ, Barbut F, Brazier JS, Kleinkauf N, Eckmanns T, Lambert ML, et al. Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Eurosurveillance, Volume 13, Issue 31, 31 July 2008.

[4] Gerding DN, Johnson S, Peterson LR, Mulligan ME, Silva J Jr. Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol. 1995;16(8):459–77.

[5] Shaughnessy MK, Micielli RL, DePestel DD, Arndt J, Strachan CL, Welch KB, et al. Evaluation of hospital room assignment and acquisition of Clostridium difficile infection. Infect Control Hosp Epidemiol. 2011;32(3):201–6.

[6] Chang VT, Nelson K. The role of physical proximity in nosocomial diarrhea. Clin Infect Dis. 2000;31(3):717–22. Epub 2000 Oct 4.

[7] Shim JK, Johnson S, Samore MH, Bliss DZ, Gerding DN. Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea. Lancet. 1998;351(9103):633–6.

[8] Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, et al.; Society for Healthcare Epidemiology of America; Infectious Diseases Society of America. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31(5):431–55.

[9] Wilkinson K, Gravel D, Taylor G, McGeer A, Simor A, Suh K, et al.; Canadian Nosocomial Infection Surveillance Program. Infection prevention and control practices related to Clostridium difficile infection in Canadian acute and long-term care institutions. Am J Infect Control. 2011;39(3):177–82.

[10] Walker AS, Eyre DW, Wyllie DH, Dingle KE, Harding RM, O’Connor L, et al. Characterisation of Clostridium difficile hospital ward-based transmission using extensive epidemiological data and molecular typing. PLoS Med. 2012;9(2):e1001172. Epub 2012 Feb 7.

[11] Palmore TN, Sohn S, Malak SF, Eagan J, Sepkowitz KA. Risk factors for acquisition of Clostridium difficile–associated diarrhea among outpatients at a cancer hospital. Infect Control Hos Epidemiol. 2005;26(8):680–4.

[12] Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.

[13] Crobach MJ, Dekkers OM, Wilcox MH, Kuijper EJ. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI). Clin Microbiol Infect. 2009;15(12):1053–66. doi: 10.1111/j.1469-0691.2009.03098.x.

[14] McDonald LC, Coignard B, Dubberke E, Song X, Horan T, Kutty PK; Ad Hoc Clostridium difficile Surveillance Working Group. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol. 2007;28(2):140–5. Epub 2007 Jan 25.

[15] Fenner L, Frei R, Gregory M, Dangel M, Stranden A, Widmer AF. Epidemiology of Clostridium difficile-associated disease at University Hospital Basel including molecular characterisation of the isolates 2006–2007. Eur J Clin Microbiol Infect Dis. 2008;27(12):1201–7. Epub 2008 Jun 17.

[16] Bauer MP, Notermans DW, van Benthem BH, Brazier JS, Wilcox MH, Rupnik M, et al.; ECDIS Study Group. Clostridium difficile infection in Europe: a hospital-based survey. Lancet. 2011;377(9759):63–73.

[17] Khanna S, Pardi DS, Aronson SL, Kammer PP, Orenstein R, St Sauver JL, et al. The epidemiology of community-acquired Clostridium difficile infection: a population-based study. Am J Gastroenterol. 2012;107(1):89–95. doi: 10.1038/ajg.2011.398. Epub 2011 Nov 22. Erratum in: Am J Gastroenterol. 2012;107(1):150.

[18] Morrison RH, Hall NS, Said M, Rice T, Groff H, Brodine SK, et al. Risk Factors Associated With Complications and Mortality in Patients With Clostridium difficile Infection. Clin Infect Dis. 2011;53(12):1173–8. Epub 2011 Oct 5.

[19] McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med. 1989;320(4):204–10.

[20] Sax H, Allegranzi B, Chraïti MN, Boyce J, Larson E, Pittet D. The World Health Organization hand hygiene observation method. Am J Infect Control. 2009;37(10):827–34.